Empowering MSMEs with News & Insights

India Pharma Expo will increase exports and domestic production

Updated: Jan 07, 2016 05:40:32pm
image
New Delhi, Jan 7 (KNN) With the view to encourage 'Make in India' for manufacturing drugs and pharma machines, an international exhibition and conference on Pharma industry, medical electronics and devices sector, has been kick-started in Bengaluru today.

The Minister of Chemicals and Fertilizers Ananth Kumar inaugurated the India Pharma 2016 and India Medical Expo 2016, which is the first such major composite event in the country for the pharmaceutical and Medical devices industry.

The 3-day event is aimed at increasing overall growth of Pharma sector including exports, and focuses on increasing domestic production in the sector.

The event also strives to encourage ‘Make in India’ for manufacturing drugs and pharma machines, and also provides a platform to global investment community to connect with stakeholders.

Speaking on the occasion, Ananth Kumar said to compete with the other countries, production cost of drugs has to be brought down, and for this purpose Government of India is coming up with Pharma clusters/parks where common facilities and infrastructure will be provided.

He said that the issues of making available credit to companies at affordable rates, and continuing the Income Tax exemptions for R&D activities will be taken up with the finance ministry.

Ananth Kumar said that for skill development and manpower availability, dozen NIPERs (National Institutes of Pharmaceutical education and research) are being set up, out of which 8 are already functional. Regarding the implementation of Katoch Committee report on bulk drugs, he said that his ministry has already accepted the recommendations, and inter-ministerial consultations are going on.

He said that Medical devices sector is upcoming, and the first Medical Device Park will be set up in Gujarat. The Minister said that the Government will have a sustained dialogue with the industry and stakeholders so that affordability (quality), availability (ease) and affordability of medicines could be ensured.

The Minister of State for Chemicals and Fertilizers, Hansraj Gangaram Ahir, addressing the gathering stressed on increased R&D activities and innovation in the sector.

The Secretary, department of Pharmaceuticals, V.K. Subburaj called upon the industry to diversify its products and its production facilities in different states rather than being concentrated in four states. Dr Subburaj asked the industry to comply with international quality standards, and also work more on R&D. (With PIB Inputs)

COMMENTS

    Be first to give your comments.

LEAVE A REPLY

Required fields are marked *